Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
  1. 2019
  2. Published
  3. Published

    To switch or not to switch: results of a nationwide guideline of mandatory switching from originator to biosimilar etanercept. One-year treatment outcomes in 2061 patients with inflammatory arthritis from the DANBIO registry

    Glintborg, B., Loft, A. G., Omerovic, E., Hendricks, O., Linauskas, A., Espesen, J., Danebod, K., Jensen, D. V., Nordin, H., Dalgaard, E. B., Chrysidis, S., Kristensen, S., Raun, J. L., Lindegaard, H., Manilo, N., Jakobsen, S. H., Hansen, I. M. J., Dalsgaard Pedersen, D., Sørensen, I. J., Andersen, L. S., Grydehøj, J., Mehnert, F., Krogh, N. S. & Hetland, M. L., 2019, In : Annals of the Rheumatic Diseases. 78, 2, p. 192-200 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. 2018
  5. Published

    Dose tapering and discontinuation of biological therapy in rheumatoid arthritis patients in remission in routine care – 2-year outcomes and identification of predictors

    Brahe, C. C. H., Krabbe, S., Østergaard, M., Ørnbjerg, L. M., Glinatsi, D. E., Røgind, H., Jensen, H. S., Hansen, A., Nørregaard, J., Jacobsen, S., Terslev, L., Huynh, T. K., Jensen, D. V., Manilo, N., Asmussen, K., Frandsen, P. B., Boesen, M., Rastiemadabadi, Z., Morsel-Carlsen, L., Møller, J. M., Krogh, N. S. & Hetland, M. L., 2018, In : Annals of the Rheumatic Diseases. 77, Suppl. 2, p. 70-1 2 p., OP0038.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  6. Published
  7. 2017
  8. Published

    A nationwide non-medical switch from originator infliximab to biosimilar CT-P13 in 802 patients with inflammatory arthritis: 1-year clinical outcomes from the DANBIO registry

    Glintborg, B., Sørensen, I. J., Loft, A. G., Lindegaard, H., Linauskas, A., Hendricks, O., Hansen, I. M. J., Jensen, D. V., Manilo, N., Espesen, J., Klarlund, M., Grydehøj, J., Dieperink, S. S., Kristensen, S., Olsen, J. S., Nordin, H., Chrysidis, S., Dalsgaard Pedersen, D., Sørensen, M. V., Andersen, L. S., Grøn, K. L., Krogh, N. S., Pedersen, L., Hetland, M. L. & all departments of rheumatology in Denmark, Aug 2017, In : Annals of the Rheumatic Diseases. 76, 8, p. 1426-1431 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Hand bone loss in early rheumatoid arthritis during a methotrexate-based treat-to-target strategy with or without adalimumab-a substudy of the optimized treatment algorithm in early RA (OPERA) trial

    Ørnbjerg, L. M., Østergaard, M., Jensen, T., Hørslev-Petersen, K., Stengaard-Pedersen, K., Junker, P., Ellingsen, T., Ahlquist, P., Lindegaard, H., Linauskas, A., Schlemmer, A., Dam, M. Y., Hansen, I., Lottenburger, T., Ammitzbøll, C. G., Jørgensen, A., Krintel, S. B., Raun, J., Hetland, M. L., Slot, O., Nielsen, L. K., Skjødt, H., Majgaard, O., Lorenzen, T., Horn, H. C., Kowalski, M., Johansen, I. L., Pedersen, P. M., Manilo, N. & Bliddal, H., 1 Apr 2017, In : Clinical Rheumatology. 36, 4, p. 781-789

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published
  11. Published

    One-Year Clinical Outcomes in 1623 Patients with Inflammatory Arthritis Who Switched from Originator to Biosimilar Etanercept – an Observational Study from the Danish Danbio Registry

    Glintborg, B., Omerovic, E., Danebod, K., Jensen, D. V., Nordin, H., Loft, A. G., Chrysidis, S., Raun, J. L., Hendricks, O., Lindegaard, H., Espesen, J., Jakobsen, S., Hansen, I. M. J., Grydehøj, J., Dalgaard, E., Pedersen, D. D., Manilo, N., Andersen, L. S., Kristensen, S., Linauskas, A., Krogh, N. S. & Hetland, M. L., 2017, In : Arthritis & Rheumatology. 69, S10, 1550.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  12. Published

    Validity and completeness of rheumatoid arthritis diagnoses in the nationwide DANBIO clinical register and the Danish National Patient Registry

    Ibfelt, E. H., Sørensen, J., Jensen, D. V., Dreyer, L., Schiøttz-Christensen, B., Thygesen, P. H., Colic, A., Raun, J. L., Manilo, N., Rødgaard, A., Poulsen, U. E., Rasmussen, C., Hansen, T., Unger, B., Pelck, R., Kincses, A., Nordin, H., Lorenzen, T., Theibich, A., Jensen Hansen, I. M., Espesen, J., Grydehøj, J., Holland-Fischer, M., Loft, A. G. & Hetland, M. L., 2017, In : Clinical Epidemiology. 9, p. 627-632 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  13. 2016
  14. Published

    Clinical and radiographic outcome of a treat-to-target strategy using methotrexate and intra-articular glucocorticoids with or without adalimumab induction: a 2-year investigator-initiated, double-blinded, randomised, controlled trial (OPERA)

    Hørslev-Petersen, K., Hetland, M. L., Ørnbjerg, L. M., Junker, P., Pødenphanth, J., Ellingsen, T., Ahlquist, P., Lindegaard, H., Linauskas, A., Schlemmer, A., Dam, M. Y., Hansen, I., Lottenburger, T., Ammitzbøll, C. G., Jørgensen, A., Krintel, S. B., Raun, J., Johansen, J. S., Østergaard, M., Stengaard-Pedersen, K., OPERA Study-Group, Slot, O., Skjødt, H., Manilo, N. & Bliddal, H., 2016, In : Annals of the Rheumatic Diseases. 75, 9, p. 1645-53 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  15. Published
  16. 2015
  17. Published
  18. 2014
  19. Published

    Impact of different infliximab dose regimens on treatment response and drug survival in 462 patients with psoriatic arthritis: results from the nationwide registries DANBIO and ICEBIO

    Glintborg, B., Gudbjornsson, B., Steen Krogh, N., Omerovic, E., Manilo, N., Holland-Fischer, M., Lindegaard, H. M., Gitte Loft, A., Nordin, H., Johnsen, L. L., Flejsborg Oeftiger, S., Hansen, A., Rasmussen, C., Grondal, G., Jon Geirsson, A. & Lund Hetland, M., Nov 2014, In : Rheumatology (Oxford, England). 53, 11, p. 2100-9 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  20. 2013
  21. Published

    Clinical response, drug survival and predictors thereof in 432 ankylosing spondylitis patients after switching tumour necrosis factor α inhibitor therapy: results from the Danish nationwide DANBIO registry

    Glintborg, B., Østergaard, M., Krogh, N. S., Tarp, U., Manilo, N., Loft, A. G. R., Hansen, A., Schlemmer, A., Fana, V., Lindegaard, H. M., Nordin, H., Rasmussen, C., Ejstrup, L., Jensen, D. V., Petersen, P. M. & Hetland, M. L., 2013, In : Annals of the Rheumatic Diseases. 72, p. 1149-1155

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 44178007